Invention Grant
- Patent Title: Complexes for delivery of antigenic peptides
-
Application No.: US16619802Application Date: 2018-06-01
-
Publication No.: US11701433B2Publication Date: 2023-07-18
- Inventor: Yu Lei , Yee Sun Tan , Kanokwan Sansanaphongpricha , Duxin Sun , Hongwei Chen , Hongxiang Hu
- Applicant: The Regents of the University of Michigan
- Applicant Address: US MI Ann Arbor
- Assignee: The Regents of the University of Michigan
- Current Assignee: The Regents of the University of Michigan
- Current Assignee Address: US MI Ann Arbor
- Agency: Casimir Jones, S.C.
- Agent Jason R. Bond
- International Application: PCT/US2018/035623 2018.06.01
- International Announcement: WO2018/226529A 2018.12.13
- Date entered country: 2019-12-05
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K47/69 ; A61K47/64 ; A61P35/00 ; A61K39/00 ; A61K39/02 ; A61K39/118 ; A61K39/385 ; B82Y5/00

Abstract:
The present invention provides methods, compositions, systems, and kits comprising nano-satellite complexes and/or serum albumin carrier complexes, which are used for modulating antigen-specific immune response (e.g., enhancing anti-tumor immunity). In certain embodiments, the nano-satellite complexes comprise: a) a core nanoparticle complex comprising a biocompatible coating surrounding a nanoparticle core; b) at least one satellite particle attached to, or absorbed to, the biocompatible coating; and c) an antigenic component conjugated to, or absorbed to, the at least one satellite particle component. In certain embodiments, the complexes further comprise: d) an type I interferon agonist agent. In some embodiments, the serum albumin complexes comprise: a) at least part of a serum albumin protein, b) an antigenic component conjugated to the carrier protein, and c) a type I interferon agonist agent.
Information query